doxorubicin-acino pulver und lösungen zur herstellung eines konzentrates
acino pharma ag - doxorubicini hydrochloridum - pulver und lösungen zur herstellung eines konzentrates - i): doxorubicini hydrochloridum 50 mg, lactosum monohydricum, pro vitro. ii): natrii carbonas anhydricus, aqua ad iniectabilia q.s. ad solutionem pro 3 ml. iii): lecithinum ex ovo, cholesterolum, natrii hydroxidum, aqua ad iniectabilia q.s. ad solutionem pro 2 ml. - zytostatikum - synthetika human
clopidogrel acino
acino ag - clopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - agenti antitrombotici - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.
bactiflox 250 compresse rivestite con film
acino pharma ag - ciprofloxacinum - compresse rivestite con film - ciprofloxacinum 250 mg a ciprofloxacini hydrochloridum, cellulosum microcristallinum, maydis per amylum, crospovidonum, silice colloidalis anhydrica, magnesio stearas, Überzug: hypromellosum, macrogolum 6000, e 171, talco, pro compresso haze. - malattie infettive - synthetika
bactiflox 500 compresse rivestite con film
acino pharma ag - ciprofloxacinum - compresse rivestite con film - ciprofloxacinum 500 mg ciprofloxacini hydrochloridum, cellulosum microcristallinum, maydis per amylum, crospovidonum, silice colloidalis anhydrica, magnesio stearas, Überzug: hypromellosum, macrogolum 6000, e 171, talco, pro compresso haze. - malattie infettive - synthetika
bactiflox 750 compresse rivestite con film
acino pharma ag - ciprofloxacinum - compresse rivestite con film - ciprofloxacinum 750 mg a ciprofloxacini hydrochloridum, cellulosum microcristallinum, maydis per amylum, crospovidonum, silice colloidalis anhydrica, magnesio stearas, Überzug: hypromellosum, macrogolum 6000, e 171, talco, pro compresso haze. - malattie infettive - synthetika
divigel 0,5 g gel
orion pharma ag - estradiolum - gel - estradiolum 0.5 mg ut estradiolum hemihydricum, carbomerum 974p, trolaminum, ethanolum 96 per centum 292.5 mg, aqua purificata, propylenglycolum 62.5 mg ad gelatum pro 0.5 g. - per transdermico trattamento di oestrogenmangelsymptomen - synthetika
divigel 1,0 g gel
orion pharma ag - estradiolum - gel - estradiolum 1 mg ut estradiolum hemihydricum, carbomerum 974p, trolaminum, ethanolum 96 per centum 585 mg, aqua purificata, propylenglycolum 125 mg ad gelatum pro 1 g. - per transdermico trattamento di oestrogenmangelsymptomen - synthetika
tamec 20 mg compresse rivestite con film
sandoz pharmaceuticals ag - tamoxifenum - compresse rivestite con film - tamoxifenum 20 mg ut tamoxifeni citras, lactosum monohydricum, carboxymethylamylum natricum a, povidonum k 25, cellulosum microcristallinum, magnesii stearas, Überzug: lactosum 1.8 mg, hypromellosum, macrogolum 4000, e 171, pro compresso obducto corresp. lactosum monohydricum 144.5 mg et natrium max. 0.84 mg. - oncologicum - synthetika
cip eco 250 compresse rivestite con film
sandoz pharmaceuticals ag - ciprofloxacinum - compresse rivestite con film - ciprofloxacinum 250 mg a ciprofloxacini hydrochloridum, excipiens pro compresso haze. - malattie infettive - synthetika
cip eco 500 compresse rivestite con film
sandoz pharmaceuticals ag - ciprofloxacinum - compresse rivestite con film - ciprofloxacinum 500 mg ciprofloxacini hydrochloridum, excipiens pro compresso haze. - malattie infettive - synthetika